Labetalol Hydrochloride, ラベタロール

Labetalol ラベタロール; Molecular FormulaC19H24N2O3 Average mass328.405 Da Labetalol hydrochloride, AH-5158A, Sch-15719W, Amipress, Trandate, Normodyne Labetalol was granted FDA approval on 1 August 1984 Presolol; (RS)-2-Hydroxy-5-{1-hydroxy-2-[(1-methyl-3-phenylpropyl)amino]ethyl}benzamide; 5-[1-Hydroxy-2-[(1-methyl-3-phenyl propyl)amino]ethyl]salicylamide A salicylamide derivative that is a non-cardioselective blocker of BETA-ADRENERGIC RECEPTORS and ALPHA-1 ADRENERGIC RECEPTORS. 253-258-3 [EINECS] 2-Hydroxy-5-{1-hydroxy-2-[(4-phenyl-2-butanyl)amino]ethyl}benzamide [ACD/IUPAC Name] 2-Hydroxy-5-{1-hydroxy-2-[(4-phenylbutan-2-yl)amino]ethyl}benzamide 36894-69-6 [RN] Benzamide, 2-hydroxy-5-(1-hydroxy-2-((1-methyl-3-phenylpropyl)amino)ethyl)- Benzamide, 2-hydroxy-5-[1-hydroxy-2-[(1-methyl-3-phenylpropyl)amino]ethyl]- [ACD/Index Name] Dilevalol Labetalol[Wiki] labetolol…

Uncategorized – New Drug Approvals

Labetalol Hydrochloride, ラベタロール

Labetalol Hydrochloride, ラベタロール

JP2022009026A - Reduced sodium poloxamer-188 formulations and

Labetalol Hydrochloride, ラベタロール

Supplement II To The Japenese Pharmacopoeia 17th, PDF

心筋－バーチャルラボラトリ

JP2020523388A - Diazabicyclic substituted imidazopyrimidines and

Labetalol Hydrochloride, ラベタロール

Labetalol Hydrochloride Pharmaceutical Secondary Standard